- The Pharmaceutical Society of Japan Award '18
- Yuji Imaizumi (Nagoya City University, Vice President, Professor)
Physiological and pathophysiological functions of ion channels as a target of drug therapy and discovery
- Hiromitsu Takayama (Graduate School of Pharmaceutical Sciences, Chiba University, Professor)
Survey, Synthesis and Medicinal Chemistry Research on Bioactive Alkaloids
- Yuji Mori (Faculty of Pharmacy, Meijo University, Professor)
Development of New Synthetic Methods and Total Synthesis of Bioactive Marine Natural Products
- The Pharmaceutical Society of Japan Award for Divisional Scientific Contribution '18
- Keiko Yamamoto (Showa Pharmaceutical University, Vice President, Professor)
Discovery of nuclear receptor ligands and elucidation of their mechanism of action
- Jun Haginaka (School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Professor)
Development of highly selective detection and high-performance separation methods for pharmaceuticals and their applications
- The Pharmaceutical Society of Japan Award for Divisional Scientific Promotion '18
- Shigeru Arai (Graduate School of Pharmaceutical Sciences, Chiba University, Associate Professor)
Design, synthesis and application of nitrogen-containing useful molecules
- Takumi Watanabe (Institute of Microbial Chemistry (BIKAKEN), Laboratory Head)
Chemical studies on bioactive natural products directed toward development of novel anti-infective and anticancer medicines
- Kouichi Yoshinari (School of Pharmaceutical Sciences, University of Shizuoka, Professor)
Studies on drug metabolism and safety based on the understanding of gene regulation mechanisms
- Tsuyoshi Nakanishi (Gifu Pharmaceutical University, Associate Professor)
Advanced study for toxicity induced by hazards in the aquatic environment via signaling pathways of nuclear receptors
- The Pharmaceutical Society of Japan Award for Young Scientists '18
- Hirofumi Ueda (Graduate School of Pharmaceutical Sciences, Tohoku University, Assistant Professor)
Total Syntheses of Complex Alkaloids based on Chemoselective Activation of Functional Groups
- Kounosuke Oisaki (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Synthetic Organic Chemistry Laboratory, Lecturer)
Development of Highly Chemoselective Oxidative Transformations by Designing Organoradicals
- Chao Wang (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Assistant Professor)
Opening a New Frontier of Molecular Transformations by the Integration of Theoretical and Experimental Approach
- Shunsuke Kotani (Priority Organization for Innovation and Excellence/Graduate School of Pharmaceutical Sciences, Kumamoto University, Associate Professor)
Development of Asymmetric Tandem Reactions Mediated by Hypervalent Silicon Complex Involving Phosphine Oxide Catalysts
- Masanori Nagatomo (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Assistant Professor)
Development of synthetic strategies for densely oxygenated natural products
- Takashi Nakamura (Faculty of Pharmaceutical Sciences, Hokkaido University, Assistant Professor)
Development of nano DDS for cancer immunotherapy based on lipid nanoparticles
- Taishi Higashi (Graduate School of Pharmaceutical Sciences, Kumamoto University, Research Associate)
Design and Evaluation of Molecular Accessories as Advanced Pharmaceutical Materials
- Maho Yagi-Utsumi (Institute for Molecular Science, National Institutes of Natural Sciences, Assistant Professor)
NMR characterization of conformational dynamics and molecular assemblies of proteins
- The Pharmaceutical Society of Japan Award for Educational Service '18
- Akinori Akaike (Wakayama Medical University, Visiting Professor)
Contribution to education reform of Pharmaceutical Sciences of six-year and four year systems
- The Pharmaceutical Society of Japan Award for Distinguished Service '18
- Masaki Otagiri (Sojo University, Professor)
- The 41st Sato Memorial Fund
- Takafumi Naito (Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Vice-director)
Optimization of individual pharmacotherapy based on the multiple evaluation of patient information
|
